| CC | CG/GG | p-value(a)
| aAMR (95% CI) | p-value(b)
|
---|
TC (mg/dL) | 156.0 (63.0) | 139.0 (49.0) |
0.008
| 0.87 (0.79; 0.95) |
0.004
|
TG (mg/dL) | 122.0 (49.0) | 122.0 (27.0) | 0.319 | 0.92 (0.81; 1.04) | 0.163 |
LDL-C (mg/dL) | 86.4 (54.1) | 72.4 (36.0) |
0.005
| 0.79 (0.68; 0.93) |
0.004
|
HDL-C (mg/dL) | 36.0 (18.0) | 36.0 (12.0) | 0.921 | 0.98 (0.89; 1.09) | 0.734 |
LDL-C/HDL-C | 2.1 (1.3) | 1.8 (1.1) |
0.027
| 0.86 (0.73; 1.01) | 0.067 |
AI | 2.7 (1.6) | 2.5 (1.4) |
0.031
| 0.87 (0.76; 1.01) | 0.069 |
- Values expressed as median [interquartile range = upper quartile (Q3) - lower quartile (Q1)] and adjusted arithmetic mean ratio (aAMR) [95% of confidence interval (95% CI)]. Statistically significant differences are shown in bold. (a)P-values were calculated by generalized linear models (GLM) with gamma distribution (log-link). (b)P-values were calculated by GLM with log-link adjusted by the most important clinical and epidemiological characteristics (see Statistical analysis section).
- Abbreviations: HCV hepatitis C virus, HIV human immunodeficiency virus, TC total cholesterol, TG triglycerides, LDL-C low density lipoprotein, HDL-C high density lipoprotein, LDL-C/HDL-C ratio of low density lipoprotein/high density lipoprotein, AI atherogenic index.